Development and in vitro evaluation of polar lipid based lipospheres for oral delivery of peptide drugs
Keywords:
Cetyl alcohol, Enzyme, factorial design, Lipospheres, Peptide, SerratiopeptidaseAbstract
A 32 factorial design was employed to produce oral sustained release lipospheres prepared by modified double emulsion solvent evaporation technique for Serratiopeptidase (acid-labile enzyme) using wax and polar lipid combination as retardants. The effects of formulation variables selected through preliminary trials namely peptide and stabilizer (Tween® 80) concentration was evaluated by F-test on the drug content and size of lipospheres. The results of analysis of variance tests for both effects indicated that the test is significant (p < 0.05). The effect of Tween® 80 concentration (SSY1- 41.66; SSY2 – 25.30) was found to be higher than peptide amount (SSY1- 3.94; SSY2 – 4.03) on the size and drug content of lipospheres. Characterization was carried out through photomicroscopy, scanning electron microscopy, particle size analysis and in vitro drug release study. The effect of formulation variables on the integrity of enzyme was confirmed by in vitro proteolytic activity. The drug release from lipospheres followed first-order kinetics and was characterized by the Higuchi diffusion and Ritger-Peppas model. Lipospheres having maximum drug content (11.93±0.89) released 3- 4% enzyme at pH 1.2 in 4 h. In phosphate buffer, lipospheres showed an initial burst release of 20.89±1.87% to 27.89±2.03% in one hour with additional 73.22±2.36% to 94.75±2.78% in next 12 hours. Thus, peptide loaded lipospheres with desirable characters in terms of maximum peptide content and diffusion release pattern were successfully prepared with formulation optimization approach.
References
Lee VHL, Robinson JR. Enzymatic Barriers to Peptide and Protein Absorption. CRC Crit. Rev. Ther. Drug Carrier Syst 1988; 5: 69-97.
Efentakis M, Koutlis A. Release of furosemide from multiple-unit and single- unit preparations containing different viscosity grades of sodium alginate. Pharm Dev Tech 2001; 6: 91-98.
Rawat M, Singh S, Saraf S, Saraf S.. Nanocarriers: Promising vehicle for bioactive drugs. Biol Pharm Bull 2006;29:1790-1798.
Reithmeier H, Herrmann J, Gopferich A. Development and characterization of lipid microparticles as a drug carrier for somatostatin. Int J Pharm 2001; 218: 133-143.
Ravi Kumar MNV. Nano and microparticles as controlled drug delivery devices. J Pharm Pharmaceut Sci 2000; 3: 234-244.
Rawat M, Singh D, Saraf S, Swarnlata Saraf. Lipid carriers: A versatile delivery vehicle for Proteins and Peptides. Yakugaku Zasshi 2008; 128: 269-280.
Domb AJ, Bergelson L, Amselem S. Lipospheres for controlled delivery of substances. In: Benita S, editor. Microencapsulation, methods and industrial applications. New York. NY: Marcel Dekker; 1996. p. 377-410.
Esposita E, Cortesi R, Nastruzzi C. Production of lipospheres for bioactive compound delivery. In: Claudio Nastruzzi editor , Lipospheres in Drug Targets and Delivery Approaches, Methods and Applications. Boca Raton. Florida: CRC Press; p.23-40.
Rawat M, Saraf S, Swarnlata Saraf. Influence of Selected Formulation Variables on the Preparation of Enzyme-entrapped Eudragit S100 Microspheres. AAPS PharmSciTech 2007; 8: Article 116
Miyata K. Intestinal absorption of Serratia peptidase. J Appl Biochem. 1980; 2: 111-116.
Zhou XH. Overcoming enzymatic and absorption barriers to non-parenterally administered protein and peptide drugs. J Control Rel 1994; 29: 239-252.
Govender S, Pillay V, Chetty DJ, Essack SY, Dangor CM, Govender T. Optimization and characterization of bioadhesive controlled release tetracycline microspheres. Int J Pharm. 2005; 306: 24-40.
Cortesi R, Esposito E, Luca G, Nastruzzi C. Production of lipospheres as carriers for bioactive compounds. Biomaterials 2002; 23: 2283-94.
Muller RH, Maassen S, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytes. J Control Rel 1997; 47: 261-9.
Saudagar RB, Rawat M, Singh D, Saraf S, Saraf S. Development and validation of derivative spectrophotometric method for determination of serratiopeptidase in pharmaceutical formulation. Oriental J Chem 2008; 23: 113-114.
Savolainen M, Herder J, Khoo C, Lövqvist K, Dahlqvist C, Glad H, Mari JA. Evaluation of polar lipid–hydrophilic polymer microparticles. Int J Pharm 2003; 262: 47-62.
Salamone PR, Wodzinski RJ. Production, purification and characterization of a 50-kDa extracellular metalloprotease from Serratia marcescens. Appl Microbiol Biotechnol 1997; 48: 317-324.
Jalil R, Nixon JR. Biodegradable poly (lactic acid) and poly (lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J Microencapsul 1990; 7: 297-325.
Shivakumar HN, Patel PB, Desai BG, Arulmozhi PAS. Design and statistical optimization of glipizide loaded lipospheres using response surface methodology. Acta Pharm 2007; 57: 269-285.
Maheshwari M, Ketkar AR, Chauhan B, Patil VB, Paradkar AR. Preparation and characterization of ibuprofen-cetyl alcohol beads by melt solidification technique: effect of variables. Int J Pharm 2003; 261: 57-67.
Nasr M, Mansour S, Mortada ND, El Shamy AA. Lipospheres as Carriers for Topical Delivery of Aceclofenac: Preparation, Characterization and In Vivo Evaluation. AAPS PharmSciTech 2008; 9: 154-162.
Kamble R, Maheshwari M, Paradkar A, Kadam Shivajirao. Melt-solidification Technique: Incorporation of higher wax content in Ibuprofen beads. AAPS PharmSciTech 2004; 5: article 61.
Iscan Y, Hekimoglu S, Sargon MF, Hincal AA. Deetloaded solid lipid particles for skin delivery: In vitro release and skin permeation characteristics in different vehicles. J Microencapsul 2006; 23: 315-327.
Segurola J, Allen NS, Edge M, McMohan A. Design of eutectic photoinitiator blends for UV/visible curable acrylated printing inks and coatings. Prog Org Coat 1999; 37: 23-37.
Mendenhall W, Sincich T. Multiple regression: A second course in business statistics: Regression analysis, 3rd ed. California: Dellen Publishing;1989.
Gibalya El, Abdel-Ghaffar SK. Effect of hexacosanol on the characteristics of novel sustained-release allopurinol solid lipospheres (SLS): factorial design application and product evaluation. Int J Pharm 2005; 294: 33-51.
Pitt CG, Cha Y, Shah SS, Zhu KJ. Blends of PVA and PLGA: control of permeability and degradability of hydrogels by blending. J Control Rel 1992; 19: 189-200.
Zhang JX, Zhu KJ. An improvement of double emulsion technique for preparing bovine serum albumin loaded PLGA microspheres. J Microencapsul 2004; 21: 775-785.
Lewis L, Boni R, Adeyeye CM. Effect of emulsifier blend on the characteristics of sustained release diclofenac microspheres. J Microencapsul 1998; 15: 283-298.
Adeyeye CM, Price JC. Development and evaluation of sustained release ibuprofen-wax microspheres. II. In vitro dissolution studies. Pharm Res 1994; 11: 575-579.
Giannola LI, De Caro V. Entrapment of phenytoin into microspheres of oleaginous materials: process development and in vitro evaluation of drug release. Drug Dev Ind Pharm 1997; 23, 1145-1152.
Dredan J, Antal I, Racz I. Evaluation of mathematical models describing drug release from lipophilic matrices. Int J Pharm 1996; 145: 61-64.
Peppas NA. Analysis of fickian and non-fickian drug release from polymers. Pharm Acta Helv 1985; 60: 110-111.
